Literature DB >> 25064826

Longitudinal strain of right ventricular free wall by 2-dimensional speckle-tracking echocardiography is useful for detecting pulmonary hypertension.

Satoshi Ikeda1, Akira Tsuneto2, Sanae Kojima3, Seiji Koga4, Tomoo Nakata4, Takeo Yoshida4, Miyuki Eto4, Takako Minami2, Katsunori Yanagihara5, Koji Maemura2.   

Abstract

AIMS: Echocardiography is widely used for screening pulmonary hypertension (PH). More recently developed two-dimensional speckle-tracking echocardiography (2D-STE) can assess regional deformation of the myocardium and is useful for detecting left ventricular dysfunction. However, its usefulness to assess right ventricular (RV) dysfunction is not clear. Therefore, the aim of this study was to investigate the ability of peak systolic strain (PSS) and post-systolic strain index (PSI) at the RV free wall determined by 2D-STE to detect PH. MAIN
METHODS: Thirty-six images (27 images from PH patients, nine from patients with connective tissue disease without PH) obtained by 2D-STE were analysed. We investigated the relationship between RV hemodynamics measured by right heart catheterization and PSS, PSI and other echocardiographic parameters reflecting RV overload including RV end-diastolic diameter (RVDd) and tricuspid valve regurgitant pressure gradient (TRPG). KEY
FINDINGS: PSS, PSI, RVDd and TRPG were all correlated with mean pulmonary arterial pressure (MPAP) and pulmonary vascular resistance (PVR). Furthermore, when PSS and MPAP were measured twice, the change in PSS was correlated with the change in MPAP (r=0.633, p=0.037). Multivariate logistic regression analysis identified PSS as the only independent factor associated with MPAP ≥ 35mmHg [odds ratio (OR), 1.616; 95% confidence interval (CI) 1.017-2.567; p=0.042] and PVR ≥ 400dyn·s·cm(-5) (OR, 1.804; 95% CI 1.131-2.877; p=0.013). Furthermore, the optimal PSS cut-off value to detect an elevated MPAP and PVR was -20.75%, based on receiver operating characteristic curve analysis. SIGNIFICANCE: PSS of the RV free wall might serve as a useful non-invasive indicator of PH.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echocardiography; Peak systolic strain; Post systolic index; Pulmonary hypertension; Speckle tracking; Tricuspid valve regurgitant pressure gradient

Mesh:

Year:  2014        PMID: 25064826     DOI: 10.1016/j.lfs.2014.06.024

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Assessment of right ventricular longitudinal strain by 2D speckle tracking imaging compared with RV function and hemodynamics in pulmonary hypertension.

Authors:  Yidan Li; Yidan Wang; Xiangli Meng; Weiwei Zhu; Xiuzhang Lu
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-29       Impact factor: 2.357

2.  Clinical study of right ventricular longitudinal strain for assessing right ventricular dysfunction and hemodynamics in pulmonary hypertension.

Authors:  Yidan Li; Yidan Wang; Xiaoguang Ye; Lingyun Kong; Weiwei Zhu; Xiuzhang Lu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

3.  Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation.

Authors:  Natalia Torrealba; Mario Navarro-Marquez; Valeria Garrido; Zully Pedrozo; Diego Romero; Yuka Eura; Elisa Villalobos; Juan Carlos Roa; Mario Chiong; Koichi Kokame; Sergio Lavandero
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

Review 4.  Strain Analysis of the Right Ventricle Using Two-dimensional Echocardiography.

Authors:  Ju-Hee Lee; Jae-Hyeong Park
Journal:  J Cardiovasc Imaging       Date:  2018-08-29

5.  Comparison of the capability of risk stratification evaluation between two- and three-dimensional speckle-tracking strain in pre-capillary pulmonary hypertension.

Authors:  Bing-Yang Liu; Wei-Chun Wu; Qi-Xian Zeng; Zhi-Hong Liu; Li-Li Niu; Yue Tian; Qin Luo; Zhi-Hui Zhao; Rui-Lin Quan; Jing-Ru Lin; Hao Wang; Jian-Guo He; Chang-Ming Xiong
Journal:  Pulm Circ       Date:  2019-12-27       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.